Schrodinger
Pharmaceutical company · New York, United States · Nasdaq: SDGR
Schrodinger is a pharmaceutical company headquartered in New York, United States. Its shares trade on Nasdaq under the ticker SDGR. It has reported private securities offerings to the US SEC, most recently $108 million sold in a notice filed in 2019.
Schrodinger at a glance
What does Schrodinger do?
Private fundraising reported to the SEC
5 Form D notices; the most recent reported $107.8 million sold (2019).
Schrodinger on the BioBridgeX marketplace
CRO · Target ID & Validation, Hit-to-Lead, Lead Optimization
Services
Therapeutic areas
Modalities
Unclaimed listing. Claim this profile
Frequently asked questions about Schrodinger
Where is Schrodinger headquartered?
Schrodinger is headquartered in New York, United States.
What does Schrodinger do?
Schrodinger is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Schrodinger a public company?
Yes. Schrodinger trades on Nasdaq under the ticker SDGR.
Similar companies
- Pfizer IncNew York City, New York, United States
- Actinium Pharmaceuticals, Inc.New York City, New York, United States
- Rocket Pharmaceuticals, Inc.New York City, New York, United States
- Progenics Pharmaceuticals IncNew York City, New York, United States
- Syndax Pharmaceuticals IncNew York City, New York, United States
- Nuvation Bio Inc.New York City, New York, United States
- Immunic, Inc.New York City, New York, United States
- SELLAS Life Sciences Group, Inc.New York City, New York, United States
Last updated 2026-09-23. Data licences